Media Advisory: CDC advisory committee recommends an influenza vaccine option for persons with egg allergy

Media Advisory: CDC advisory committee recommends an influenza vaccine option for persons with egg allergy

Media Advisory: CDC advisory committee recommends an influenza vaccine option for persons with egg allergy

Centers for Disease Control and Prevention (CDC) sent this bulletin at 06/21/2013 11:30 AM EDT

Having trouble viewing this email? View it as a Web page.

Media Advisory

Immediate Release: Thursday, June 20, 2013
Contact: Division of News & Electronic Media, Office of Communication
(404) 639-3286

CDC advisory committee recommends an influenza vaccine option for persons with egg allergy

The Advisory Committee on Immunization Practices (ACIP) voted today, 13 to 0, in favor of recommending FluBlok during the 2013-2014 influenza seasons for vaccination of persons 18 through 49 years of age with egg allergy of any severity. FluBlok was licensed by the Food and Drug Administration (FDA) in January 2013. Unlike current production methods for other available seasonal influenza vaccines, FluBlok does not use the influenza virus or chicken eggs in its manufacturing process.

Read more>>